Nefazodone Hydrochloride (Teva Pharmaceuticals USA Inc)
Welcome to the PulseAid listing for the Nefazodone Hydrochloride drug offered from Teva Pharmaceuticals USA Inc. This Serotonin Reuptake Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Teva Pharmaceuticals USA Inc |
NON-PROPRIETARY NAME: | Nefazodone Hydrochloride |
SUBSTANCE NAME: | NEFAZODONE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Serotonin Reuptake Inhibitor [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2003-09-16 |
END MARKETING DATE: | 0000-00-00 |
Nefazodone Hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Nefazodone Hydrochloride from Teva Pharmaceuticals USA Inc |
LABELER NAME: | Teva Pharmaceuticals USA Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/1) |
START MARKETING DATE: | 2003-09-16 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0093-1024_9d324986-7cd7-4e49-8651-11aad2df633d |
PRODUCT NDC: | 0093-1024 |
APPLICATION NUMBER: | ANDA076037 |
Other NEFAZODONE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: